CLTR COULTER PHARMACEUTICAL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLTR COULTER PHARMACEUTICAL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ben Wa who wrote (277)	8/30/1999 7:13:00 PM
From: kendall harmon	Read Replies (3) of 666

CLTR--more on this one: quote.bloomberg.com ''(The FDA) didn't call into question the safety or efficacy of the drug,'' said Coulter Chief Medical Officer George Tidmarsh. ''They didn't ask for any new trials. They didn't ask for any new patients on ongoing trials. They didn't ask any questions on the manufacturing of the product.''

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next